US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist

57.540
+1.620+2.90%

Close Nov 22 16:00 ET

57.540
0.0000.00%

Post 20:01 ET

6.03BMarket Cap45.67P/E (TTM)

Corcept Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

39.54%73.83M

-2.61%41.18M

-8.48%23.76M

5.58%127.04M

-82.37%5.89M

57.24%52.91M

134.40%42.29M

-26.36%25.96M

-28.33%120.32M

-32.45%33.39M

Net income from continuing operations

50.47%47.21M

28.92%35.49M

74.83%27.76M

4.66%106.14M

88.87%31.36M

-9.33%31.38M

0.42%27.53M

-30.35%15.88M

-9.86%101.42M

-48.21%16.6M

Depreciation and amortization

72.66%499K

-78.98%198K

-79.16%179K

-31.46%2.36M

-77.78%272K

-61.57%289K

41.02%942K

7.11%859K

-0.86%3.45M

1.49%1.22M

Deferred tax

-71.69%-15.21M

-36.39%-13.96M

-6.48%-7.16M

13.01%-29.49M

17.80%-3.67M

0.18%-8.86M

3.69%-10.24M

32.30%-6.73M

-880.14%-33.91M

-294.30%-4.47M

Change In working capital

40.61%28.09M

-47.56%7.28M

-217.54%-7.41M

48.37%8.22M

-411.68%-31.94M

648.19%19.98M

228.69%13.87M

-35.09%6.31M

1,288.63%5.54M

478.60%10.25M

-Change in receivables

-183.65%-5.88M

191,925.00%7.68M

-326.33%-6.4M

42.26%-10.07M

58.47%-6.5M

-65.84%-2.07M

100.41%4K

-435.57%-1.5M

-1,121.58%-17.43M

-1,300.45%-15.64M

-Change in inventory

298.71%1.08M

-282.32%-1.68M

76.16%983K

5.50%1.27M

163.20%329K

-229.83%-544K

12.71%922K

442.33%558K

-65.19%1.2M

-84.16%125K

-Change in prepaid assets

200.64%6.59M

-814.75%-1.74M

395.47%3.61M

-76.96%-11.6M

-203.75%-6.02M

23.54%-6.55M

106.45%244K

8,200.00%729K

-63.68%-6.56M

437.95%5.81M

-Change in payables and accrued expense

-10.38%26.19M

-72.90%3.6M

-180.29%-5.69M

-3.41%31.39M

-180.85%-18.19M

362.81%29.22M

311.60%13.28M

-28.89%7.09M

1,892.83%32.5M

578.88%22.5M

-Change in other current assets

---34K

---551K

--153K

24.91%-1.48M

---1.48M

--0

-203.03%-1.98M

----

-Change in other current liabilities

297.22%142K

94.96%-29K

86.80%-75K

41.38%-1.29M

86.88%-74K

87.07%-72K

-4.17%-575K

-7.98%-568K

-8.59%-2.2M

-8.46%-564K

Cash from discontinued investing activities

Operating cash flow

39.54%73.83M

-2.61%41.18M

-8.48%23.76M

5.58%127.04M

-82.37%5.89M

57.24%52.91M

134.40%42.29M

-26.36%25.96M

-28.33%120.32M

-32.45%33.39M

Investing cash flow

Cash flow from continuing investing activities

59.81%-44.04M

-149.80%-60.19M

-104.34%-9.01M

179.51%90.91M

199.17%17.1M

-2,187.47%-109.57M

42.35%-24.1M

510.87%207.48M

-183.99%-114.33M

-112.27%-17.24M

Net PPE purchase and sale

-4,318.92%-1.64M

----

66.34%-139K

--0

89.46%-37K

----

11.94%-413K

52.31%-31K

Net investment purchase and sale

61.29%-42.4M

-149.13%-59.78M

-104.34%-9.01M

179.92%91.05M

199.35%17.1M

-2,367.52%-109.53M

42.57%-24M

510.97%207.48M

-183.40%-113.91M

-112.25%-17.21M

Cash from discontinued investing activities

Investing cash flow

59.81%-44.04M

-149.80%-60.19M

-104.34%-9.01M

179.51%90.91M

199.17%17.1M

-2,187.47%-109.57M

42.35%-24.1M

510.87%207.48M

-183.99%-114.33M

-112.27%-17.24M

Financing cash flow

Cash flow from continuing financing activities

-438.61%-21.09M

98.52%-2.15M

-400.00%-543K

-760.47%-148.72M

1,355.74%766K

71.95%-3.92M

-5,188.61%-145.75M

135.77%181K

94.29%-17.28M

99.97%-61K

Net common stock issuance

--0

----

---145.43M

--0

----

--0

Proceeds from stock option exercised by employees

-925.98%-9.44M

-116.09%-241K

-13.91%1.21M

32.64%5.81M

124.33%1.76M

-83.33%1.14M

132.26%1.5M

1.95%1.41M

-73.01%4.38M

-74.24%785K

Net other financing activities

-130.30%-11.65M

-4.66%-1.91M

-43.00%-1.76M

57.97%-9.11M

-17.61%-995K

---5.06M

---1.82M

34.96%-1.23M

5.12%-21.67M

66.38%-846K

Cash from discontinued financing activities

Financing cash flow

-438.61%-21.09M

98.52%-2.15M

-400.00%-543K

-760.47%-148.72M

1,355.74%766K

71.95%-3.92M

-5,188.61%-145.75M

135.77%181K

94.29%-17.28M

99.97%-61K

Net cash flow

Beginning cash position

-25.40%128.59M

-50.07%149.75M

104.36%135.55M

-14.54%66.33M

122.52%111.8M

387.68%172.38M

384.86%299.94M

-14.54%66.33M

1.87%77.62M

-46.94%50.24M

Current changes in cash

114.36%8.7M

83.41%-21.16M

-93.92%14.2M

713.24%69.22M

47.65%23.75M

-506.64%-60.58M

-381.09%-127.57M

1,582.79%233.61M

-891.03%-11.29M

194.23%16.09M

End cash Position

22.80%137.29M

-25.40%128.59M

-50.07%149.75M

104.36%135.55M

122.52%111.8M

387.68%172.38M

384.86%299.94M

-14.54%66.33M

Free cash flow

36.54%72.19M

-3.36%40.77M

-8.48%23.76M

5.83%126.9M

-82.35%5.89M

58.79%52.87M

134.08%42.18M

-26.33%25.96M

-28.38%119.91M

-32.42%33.36M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	39.54%73.83M	-2.61%41.18M	-8.48%23.76M	5.58%127.04M	-82.37%5.89M	57.24%52.91M	134.40%42.29M	-26.36%25.96M	-28.33%120.32M	-32.45%33.39M
Net income from continuing operations	50.47%47.21M	28.92%35.49M	74.83%27.76M	4.66%106.14M	88.87%31.36M	-9.33%31.38M	0.42%27.53M	-30.35%15.88M	-9.86%101.42M	-48.21%16.6M
Depreciation and amortization	72.66%499K	-78.98%198K	-79.16%179K	-31.46%2.36M	-77.78%272K	-61.57%289K	41.02%942K	7.11%859K	-0.86%3.45M	1.49%1.22M
Deferred tax	-71.69%-15.21M	-36.39%-13.96M	-6.48%-7.16M	13.01%-29.49M	17.80%-3.67M	0.18%-8.86M	3.69%-10.24M	32.30%-6.73M	-880.14%-33.91M	-294.30%-4.47M
Change In working capital	40.61%28.09M	-47.56%7.28M	-217.54%-7.41M	48.37%8.22M	-411.68%-31.94M	648.19%19.98M	228.69%13.87M	-35.09%6.31M	1,288.63%5.54M	478.60%10.25M
-Change in receivables	-183.65%-5.88M	191,925.00%7.68M	-326.33%-6.4M	42.26%-10.07M	58.47%-6.5M	-65.84%-2.07M	100.41%4K	-435.57%-1.5M	-1,121.58%-17.43M	-1,300.45%-15.64M
-Change in inventory	298.71%1.08M	-282.32%-1.68M	76.16%983K	5.50%1.27M	163.20%329K	-229.83%-544K	12.71%922K	442.33%558K	-65.19%1.2M	-84.16%125K
-Change in prepaid assets	200.64%6.59M	-814.75%-1.74M	395.47%3.61M	-76.96%-11.6M	-203.75%-6.02M	23.54%-6.55M	106.45%244K	8,200.00%729K	-63.68%-6.56M	437.95%5.81M
-Change in payables and accrued expense	-10.38%26.19M	-72.90%3.6M	-180.29%-5.69M	-3.41%31.39M	-180.85%-18.19M	362.81%29.22M	311.60%13.28M	-28.89%7.09M	1,892.83%32.5M	578.88%22.5M
-Change in other current assets	---34K	---551K	--153K	24.91%-1.48M	---1.48M	--0	--0	--0	-203.03%-1.98M	----
-Change in other current liabilities	297.22%142K	94.96%-29K	86.80%-75K	41.38%-1.29M	86.88%-74K	87.07%-72K	-4.17%-575K	-7.98%-568K	-8.59%-2.2M	-8.46%-564K
Cash from discontinued investing activities
Operating cash flow	39.54%73.83M	-2.61%41.18M	-8.48%23.76M	5.58%127.04M	-82.37%5.89M	57.24%52.91M	134.40%42.29M	-26.36%25.96M	-28.33%120.32M	-32.45%33.39M
Investing cash flow
Cash flow from continuing investing activities	59.81%-44.04M	-149.80%-60.19M	-104.34%-9.01M	179.51%90.91M	199.17%17.1M	-2,187.47%-109.57M	42.35%-24.1M	510.87%207.48M	-183.99%-114.33M	-112.27%-17.24M
Net PPE purchase and sale	-4,318.92%-1.64M	----	----	66.34%-139K	--0	89.46%-37K	----	----	11.94%-413K	52.31%-31K
Net investment purchase and sale	61.29%-42.4M	-149.13%-59.78M	-104.34%-9.01M	179.92%91.05M	199.35%17.1M	-2,367.52%-109.53M	42.57%-24M	510.97%207.48M	-183.40%-113.91M	-112.25%-17.21M
Cash from discontinued investing activities
Investing cash flow	59.81%-44.04M	-149.80%-60.19M	-104.34%-9.01M	179.51%90.91M	199.17%17.1M	-2,187.47%-109.57M	42.35%-24.1M	510.87%207.48M	-183.99%-114.33M	-112.27%-17.24M
Financing cash flow
Cash flow from continuing financing activities	-438.61%-21.09M	98.52%-2.15M	-400.00%-543K	-760.47%-148.72M	1,355.74%766K	71.95%-3.92M	-5,188.61%-145.75M	135.77%181K	94.29%-17.28M	99.97%-61K
Net common stock issuance	--0	----	----	---145.43M	--0	--0	----	----	--0	--0
Proceeds from stock option exercised by employees	-925.98%-9.44M	-116.09%-241K	-13.91%1.21M	32.64%5.81M	124.33%1.76M	-83.33%1.14M	132.26%1.5M	1.95%1.41M	-73.01%4.38M	-74.24%785K
Net other financing activities	-130.30%-11.65M	-4.66%-1.91M	-43.00%-1.76M	57.97%-9.11M	-17.61%-995K	---5.06M	---1.82M	34.96%-1.23M	5.12%-21.67M	66.38%-846K
Cash from discontinued financing activities
Financing cash flow	-438.61%-21.09M	98.52%-2.15M	-400.00%-543K	-760.47%-148.72M	1,355.74%766K	71.95%-3.92M	-5,188.61%-145.75M	135.77%181K	94.29%-17.28M	99.97%-61K
Net cash flow
Beginning cash position	-25.40%128.59M	-50.07%149.75M	104.36%135.55M	-14.54%66.33M	122.52%111.8M	387.68%172.38M	384.86%299.94M	-14.54%66.33M	1.87%77.62M	-46.94%50.24M
Current changes in cash	114.36%8.7M	83.41%-21.16M	-93.92%14.2M	713.24%69.22M	47.65%23.75M	-506.64%-60.58M	-381.09%-127.57M	1,582.79%233.61M	-891.03%-11.29M	194.23%16.09M
End cash Position	22.80%137.29M	-25.40%128.59M	-50.07%149.75M	104.36%135.55M	104.36%135.55M	122.52%111.8M	387.68%172.38M	384.86%299.94M	-14.54%66.33M	-14.54%66.33M
Free cash flow	36.54%72.19M	-3.36%40.77M	-8.48%23.76M	5.83%126.9M	-82.35%5.89M	58.79%52.87M	134.08%42.18M	-26.33%25.96M	-28.38%119.91M	-32.42%33.36M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data